Budesonide Inhibits Intracellular Infection with Non-Typeable Haemophilus influenzae despite Its Anti-Inflammatory Effects in Respiratory Cells and Human Lung Tissue: A Role for p38 MAP Kinase
Authors:
- Christopher WagnerCWChristopher Wagner
- Torsten GoldmannTGTorsten Goldmann
- Kristina RohmannKRKristina Rohmann
- Jan RuppJRJan Rupp
- Sebastian MarwitzSMSebastian Marwitz
- Johannes Rotta Detto LoriaJLJohannes Rotta Detto Loria
- Stefan LimmerSLStefan Limmer
- Peter ZabelPZPeter Zabel
- Klaus DalhoffKDKlaus Dalhoff
- Daniel DrömannDDDaniel Drömann
- 10 October 2015
- journal article
- basic science-investigations
- Published by S. Karger AG in Respiration
- Vol. 90 (5) , 416-425
Abstract
Background: Inhaled corticosteroids (ICS) are widely used in the treatment of obstructive lung diseases. Recent data suggest a higher pneumonia risk in chronic obstructive pulmonary disease (COPD) patients treated with ICS. Objective: Since non-typeable Haemophilus influenzae (NTHi) is the most common pathogen associated with acute exacerbations of COPD, we investigated the effects of budesonide (BUD) on NTHi-induced inflammation and invasive infection. Methods: The alveolar epithelial cell line A549 and specimens of human lung tissue (HLT) were used in our experiments. Intracellular infection was determined by a lysis/culture assay of infected cells. Activated p38 mitogen-associated protein kinase (MAPK) was assessed using Western blotting and immunohistochemistry, expression of toll-like receptor 2 (TLR2) was determined by PCR, and CXCL-8 levels were measured using ELISA. Immunohistochemistry was used for detection of CXCL-8, platelet-activating factor receptor (PAF-R) and NTHi. Results: BUD significantly reduced CXCL-8 secretion in A549 cells and lung tissue infected with NTHi. Furthermore, BUD decreased the expression of PAF-R in HLT and A549 cells. In A549 cells and HLT, BUD inhibited intracellular infection and - synergistically with NTHi - increased the expression of TLR2 (in A549 cells). TLR2 stimulation did not influence the intracellular infection of A549 cells, but p38 MAPK inhibition resulted in a significant reduction of infection. Conclusion: The present study adds new insights into the effects of glucocorticoids on pulmonary host defence after NTHi infection. Although the inflammatory response to infection is suppressed by BUD, interestingly, the intracellular infection is also inhibited. This effect seems to depend on the inhibition of p38 MAPK - a key enzyme in many pro-inflammatory pathways - as well as of PAF-R expression.Keywords
This publication has 39 references indexed in Scilit:
- Budesonide suppresses pulmonary antibacterial host defense by down-regulating cathelicidin-related antimicrobial peptide in allergic inflammation mice and in lung epithelial cellsBMC Immunology, 2013
- The Role of TLR2 and Bacterial Lipoprotein in Enhancing Airway Inflammation and ImmunityFrontiers in Immunology, 2011
- An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary diseaseInternational Journal of Chronic Obstructive Pulmonary Disease, 2010
- The TGF-beta-Pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzaeRespiratory Research, 2010
- Differential effects of cytokines and corticosteroids on Toll-like receptor 2 expression and activity in human airway epitheliaRespiratory Research, 2009
- TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimensDiagnostic Pathology, 2008
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2007
- Increased activation of p38 MAPK in COPDEuropean Respiratory Journal, 2007
- Role of nontypeable Haemophilus Influenzae in exacerbations and progression of chronic obstructive pulmonary diseaseCurrent Opinion in Pulmonary Medicine, 2006
- Relationship between lung tissue and blood plasma concentrations of inhaled budesonideBiopharmaceutics & Drug Disposition, 1993